Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2018 | 2014
Number of items: 2.

2018

von Tresckow, Bastian, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Haverkamp, Heinz, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2018). Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2014

von Tresckow, Bastian, Pluetschow, Annette, Haverkamp, Heinz, Vucinic, Vladan, Rank, Andreas, Topp, Max S., Feuring-Buske, Michaela, Kobe, Carsten, Kuhnert, Georg, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2014). A Phase I Study of Everolimus in Combination with Time-Intensified DHAP ( Dexamethasone, High-Dose AraC [Cytarabine], Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Sat Nov 27 05:55:43 2021 CET.